Vantage Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$618K Buy
9,669
+591
+7% +$37.7K 0.13% 85
2018
Q2
$526K Sell
9,078
-702
-7% -$39.6K 0.13% 86
2018
Q1
$508K Sell
9,780
-17,565
-64% -$949K 0.13% 89
2017
Q4
$1.47M Sell
27,345
-71,816
-72% -$3.98M 0.34% 55
2017
Q3
$6.06M Buy
99,161
+7,772
+9% +$471K 1.56% 18
2017
Q2
$5.59M Buy
91,389
+21,700
+31% +$1.32M 1.61% 19
2017
Q1
$4.22M Buy
69,689
+8,757
+14% +$531K 1.39% 26
2016
Q4
$3.42M Sell
60,932
-659
-1% -$38.6K 1.39% 27
2016
Q3
$3.67M Sell
61,591
-2,036
-3% -$119K 1.63% 20
2016
Q2
$3.49M Buy
63,627
+721
+1% +$38.4K 1.47% 20
2016
Q1
$3.18M Buy
62,906
+8,890
+16% +$435K 1.4% 22
2015
Q4
$2.72M Buy
54,016
+4,622
+9% +$233K 1.37% 21
2015
Q3
$2.33M Buy
49,394
+5,665
+13% +$301K 1.31% 23
2015
Q2
$2.38M Sell
43,729
-38,032
-47% -$2.13M 1.31% 23
2015
Q1
$4.48M Buy
81,761
+38,221
+88% +$2.16M 1.27% 25
2014
Q4
$2.36M Buy
43,540
+530
+1% +$29.5K 1.33% 23
2014
Q3
$2.43M Buy
43,010
+2,158
+5% +$121K 1.48% 24
2014
Q2
$2.25M Buy
40,852
+443
+1% +$24.2K 1.38% 23
2014
Q1
$2.19M Buy
40,409
+1,162
+3% +$60.2K 1.44% 25
2013
Q4
$1.87M Buy
+39,247
New +$1.79M 1.28% 26

Other funds holding MRK

Vantage Investment Advisors's MRK Position: Q3 2018 in Review

Vantage Investment Advisors increased its Merck (MRK) stake by 6.5% in Q3 2018, buying an estimated $37.7K and bringing the position to 9,669 shares worth $618K. The position accounts for 0.13% of the portfolio, ranked #85.

Vantage Investment Advisors first reported a position in MRK in Q4 2013 and has held it in 20 quarters since. The position peaked at $6.06M in Q3 2017. 2,056 funds tracked by Wall St. Rank hold MRK as of Q3 2018.

  • Vantage Investment Advisors held 9,669 shares of Merck worth $618K as of Q3 2018.
  • Vantage Investment Advisors bought 591 Merck shares in Q3 2018, an estimated $37.7K.
  • Merck made up 0.13% of Vantage Investment Advisors's portfolio in Q3 2018, its #85 holding.
  • Vantage Investment Advisors first reported a position in Merck in Q4 2013 and has held it in 20 quarters since.
  • Vantage Investment Advisors's Merck position peaked at $6.06M in Q3 2017.
  • 2,056 funds tracked by Wall St. Rank held Merck as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.